EN DE

SciDev Limited (SDV) Fair Value & Analysis

Basic Materials · AU · Market cap A$25.7M

SL SciDev Limited SDV · AU
PriceA$0.1650
Fair ValueA$0.1480
Upside-10.3%
Quality48/100
Watch SciDev Limited for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -2.9% net margin
Low debt · generates free cash flow
Trails peers (5/13)
Narrow moat 13/100
Evidence: Medium Range A$0.1115 – A$0.1845 Share as image

Fair value as of: Jul 18, 2026

From 15 valuation models · updated 24 days ago

Fair value updated Jul 18, 2026, revised from A$0.0713 to A$0.1480 (+107.6%) since Jun 26, 2026. Share price +22.2% over the past month.

Below-average quality, and screening another 10% overvalued on our models.

What matters now

  • Our model range runs from A$0.1115 (bear) to A$0.1845 (bull), base A$0.1480. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 48/100 (below-average quality) with medium evidence: read the verdict with care.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

A$0.9650 A$0.0870 Fair Value A$0.1480 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.

How to read this chart

60‑month range A$0.0870 – A$0.9650 · fair‑value band A$0.1115 – A$0.1845 · the A$0.1650 price screens above the A$0.1480 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 18, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

SciDev Limited (SDV) currently trades at A$0.1650, while our model-based Fair Value estimate is A$0.1480, implying the stock looks roughly 10.3% overvalued today. The Quality Score stands at 48/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, SciDev Limited generated revenue of A$102M at a net margin of -2.9%. Revenue declined 3.8% year over year. It earns a return on equity of -6.0%. The balance sheet holds a net cash position of A$3.4M. Fundamentals as of Jul 18, 2026

Our scenario range runs from A$0.1115 (bear case) to A$0.1845 (bull case); at A$0.1650, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 68% below its 52-week high and 90% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -10%, SDV screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF A$0.0900 A$0.1200 A$0.1600 80
ROIC Compounder A$0.4300 A$0.5900 A$0.6700 72
Gordon GGM A$0.5100 A$0.8600 A$1.12 70
All 15 models by family
DCF Models
FCF DCF A$0.0900 A$0.1100 A$0.1700 38
Owner Earnings A$0.1100 A$0.1800 A$0.3000 31
5Y Revenue Exit A$0.4200 A$0.7900 A$1.58 39
5Y EBITDA Exit A$0.4400 A$0.8400 A$1.61 41
10Y Revenue Exit A$0.2800 A$0.7500 A$1.10 36
10Y EBITDA Exit A$0.3100 A$0.7900 A$1.67 37
Earnings-Based
EPV A$0.3600 A$0.4000 A$0.4300 59
Dividend Discount
Gordon GGM A$0.5100 A$0.8600 A$1.12 70
DDM Multi-Stage A$0.5100 A$0.8200 A$0.9300 61
Multiples
EV/EBIT A$0.6400 A$0.8500 A$1.05 53
EV/EBITDA A$0.6400 A$0.8400 A$1.03 54
EV/Revenue A$0.5600 A$0.7900 A$1.01 43
Asset-Based
NCAV (Graham) A$0.1300 A$0.1800 A$0.2600 50
Growth DCF
Growth DCF A$0.0900 A$0.1200 A$0.1600 80
Economic Profit
ROIC Compounder A$0.4300 A$0.5900 A$0.6700 72

Widest divergence: Multiples (A$0.8400) versus Growth DCF (A$0.1200). Highest evidence: Growth DCF (80).

Notify me when SDV reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) A$102M
Revenue growth (YoY) -3.8%
Net margin -2.9%
Return on equity -6.0%
Free cash flow A$785K FY2025
Operating margin -3.6%
More key figures
EPS (TTM) A$-0.0200
EPS growth (YoY) +200%
Net cash A$3.4M FY2025

Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 48/100

Of which business quality 49 · Market factors (momentum, volatility) 30

Profitability 43
Margins and returns on capital today
Quality Growth 21
Are margins and returns improving?
Cashflow 14
Earnings quality: real cash, not paper profit
Fin. Strength 71
Balance sheet, leverage, solvency risk
Investment 96
Disciplined investing over empire-building
Low Volatility 43
Calm price path (market factor)
Momentum 33
Price trend over the last 3–12 months (market factor)
52W Momentum 9
Distance to the 52-week high (market factor)
Net Issuance 70
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

SciDev Limited engages in the provision of environmental solutions focused on water intensive industries in Australia, the United States, Asia, and internationally. The company operates in two segments, Chemical Services and Water Technologies.

Full company description

SciDev Limited engages in the provision of environmental solutions focused on water intensive industries in Australia, the United States, Asia, and internationally. The company operates in two segments, Chemical Services and Water Technologies. It develops, manufactures, and supplies proprietary chemicals, including natural and synthetic polymers for flocculation, filtration, sludge dewatering, friction reduction, shale inhibition, rheology control, and pipe-on-pipe lubrication applications; flocculants and coagulants; and provides services, such as design and engineering, process optimization, specialty chemical fluid formulations, and application equipment, as well as project management services. The company also offers water treatment technologies comprising water treatment for mobile, temporary, and permanent treatment systems; PFAS treatment solutions; onsite liquid waste treatment services; and water quality monitoring systems. It serves its products to mining and minerals processing, wastewater treatment, construction and infrastructure, oil and gas, and remediation markets. The company was formerly known as Intec Limited and changed its name to SciDev Limited in March 2017. SciDev Limited was incorporated in 1973 and is based in Sydney, Australia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

SciDev Limited reported revenue of A$104M in FY2025 versus A$42.5M in FY2021, a compound +24.9%/yr. Reported net income was −A$878K in FY2025.

Growth Quality 56/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
A$104M
Latest YoY
−5.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+23.0%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+42.0%
Avg. growth/yr (25Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+30.3%
Revenue +24.9%/yr
FY21 A$42.5M
FY22 A$55.6M
FY23 A$89.7M
FY24 A$109M
FY25 A$104M
Net income
FY21 A$3.5M
FY22 −A$616K
FY23 −A$339K
FY24 A$2.2M
FY25 −A$878K

SDV screens 10% overvalued. Compare with Linde plc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "SciDev Limited Fair Value". https://www.fairvalue-calculator.com/stock/SDV

Peer Group

Specialty Chemicals · 673 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 48 · Below median
Fair Value upside −9% · Above median
Return on assets -0% · Bottom 25%
Net margin (TTM) -3% · Bottom 25%
Operating margin (TTM) -4% · Bottom 25%
Revenue growth -4% · Below median
Debt / equity 0.04× · Lower than median

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/B 0.36× · Cheaper than 75% of peers
P/S (TTM) 0.18× · Cheaper than 75% of peers
P/FCF 23.1× · Pricier than 75% of peers
EV/EBITDA 4.5× · Cheaper than 75% of peers
PEG 2.08× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 21 · sector 0
FUTURE 0 · sector 19
PAST 0 · sector 23
HEALTH 98 · sector 95
DIVIDEND 0 · sector 25

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $489.98 $222.03 -55%
Nan Ya Plastics Corporation 1303 181.50 TWD 255.83 TWD +41%
Wanhua Chemical Group 600309 ¥70.04 ¥68.03 -3%
Novozymes A/S NSISB kr 428.20 kr 179.66 -58%
Asian Paints Limited ASIANPAINT ₹2,689 ₹668.81 -75%
Solar Industries India Limited SOLARINDS ₹18,236 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,560 ₹351.84 -77%
PT Chandra Asri Pacific Tbk TPIA 1,805 IDR 2,888 IDR +60%
Linde India Limited LINDEINDIA ₹7,115 ₹757.93 -89%
Berger Paints India Limited BERGEPAINT ₹493.70 ₹164.29 -67%

Compare SciDev Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is SciDev Limited (SDV) overvalued or undervalued?
As of Jul 18, 2026, our model estimates a fair value of A$0.1480 versus a price of A$0.1650, about −10% (overvalued).
What is the fair value of SDV?
Our model-based fair value for SciDev Limited is A$0.1480 (as of Jul 18, 2026), built from audited fundamentals. The current price is A$0.1650.
What is the quality score of SDV?
SciDev Limited has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of SciDev Limited (SDV)?
SciDev Limited reported trailing-twelve-month revenue of about A$102M (latest available figure, as of Jul 18, 2026).
What is the net profit margin of SDV?
The net profit margin of SciDev Limited is about -2.9%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track SciDev Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.